Clinical Trials Browser

Phase 2 × Hepatoblastoma × Doxorubicin × Clear all

NCT00077389 2014-06-24

Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma

Phase 2 Unknown

Gastrointestinal

Liver Neoplasms, Hepatoblastoma